Navocaftor
[5-[3-amino-5-[4-(trifluoromethoxy)phenyl]sulfonyl-2-pyridinyl]-1,3,4-oxadiazol-2-yl]methanol
Molecular Identity
Navocaftor
[5-[3-amino-5-[4-(trifluoromethoxy)phenyl]sulfonyl-2-pyridinyl]-1,3,4-oxadiazol-2-yl]methanol
PubChem CID: 132189640
2D Structure
Properties
C15H11F3N4O5S
Molecular Formula
416.30
Molecular Weight
g/mol
416.0402
Exact Mass
Da
0.8
XLogP
Drug-like (Lipinski: < 5)
150
TPSA
May have limited oral absorption
2
H-Bond Donors
12
H-Bond Acceptors
624
Complexity
SMILES
Canonical SMILES
SMILES: C1=CC(=CC=C1OC(F)(F)F)S(=O)(=O)C2=CC(=C(N=C2)C3=NN=C(O3)CO)NIsomeric SMILES
SMILES: C1=CC(=CC=C1OC(F)(F)F)S(=O)(=O)C2=CC(=C(N=C2)C3=NN=C(O3)CO)NSynonyms(20)
Navocaftor2159103-66-7Navocaftor [INN]GLPG3067Navocaftor [USAN]ABBV-3067UNII-W2F2XU189OW2F2XU189OGLPG-30671,3,4-Oxadiazole-2-methanol, 5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-pyridinyl)-(5-(3-Amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)methanolRefChem:164886Navocaftor [USAN:INN]WHO 11090[5-[3-amino-5-[4-(trifluoromethoxy)phenyl]sulfonylpyridin-2-yl]-1,3,4-oxadiazol-2-yl]methanol
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Navocaftor
Loading drug network...